Comorbidities and Risk Factors for Severe Outcomes in COVID-19 Patients in Saudi Arabia: A Retrospective Cohort Study
Autor: | Sunday O. Olatunji, Abdussalam Alshehri, Abdullah Alqahtani, Abdullah M. Almuhaideb, Mohammed Alshahrani, Waad Sami O Atiyah, Nahier Aldhafferi, Subhodeep Dey, Fatema S. Shaikh, Saema Abdulhamid, Sara Mhd. Bachar Chrouf, Yousof Zohair Almunsour, Areej Buker, Dalal Ali Mahaii AlBuhairi, Raha Saud Abdulaziz Alkabour, Vahitha B Abdul-Salam |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
mortality rate comorbidities law.invention KSA law Internal medicine risk factors Medicine General Nursing Original Research SARS-CoV-2 business.industry Journal of Multidisciplinary Healthcare Medical record Mortality rate COVID-19 Retrospective cohort study General Medicine medicine.disease Intensive care unit Comorbidity Confidence interval Cohort business Body mass index |
Zdroj: | Journal of Multidisciplinary Healthcare |
ISSN: | 1178-2390 5591-6600 |
DOI: | 10.2147/jmdh.s317884 |
Popis: | Fatema S Shaikh,1 Nahier Aldhafferi,1 Areej Buker,1 Abdullah Alqahtani,1 Subhodeep Dey,2 Saema Abdulhamid,1 Dalal Ali Mahaii AlBuhairi,1 Raha Saud Abdulaziz Alkabour,1 Waad Sami O Atiyah,1 Sara Bachar Chrouf,1 Abdussalam Alshehri,3 Sunday Olusanya Olatunji,1 Abdullah M Almuhaideb,1 Mohammed S Alshahrani,4 Yousof AlMunsour,1 Vahitha B Abdul-Salam5 1College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, Dammam, Eastern Province, Saudi Arabia; 2Indian Institute of Management â Calcutta, Kolkata, India; 3Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia; 4College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Eastern Province, Saudi Arabia; 5Centre for Cardiovascular Medicine and Device Innovation, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKCorrespondence: Fatema S Shaikh Tel +966-5591660024Email fsshaikh@iau.edu.saPurpose: The first novel coronavirus disease-19 (COVID-19) case in the Kingdom of Saudi Arabia (KSA) was reported in Qatif in March 2020 with continual increase in infection and mortality rates since then. In this study, we aim to determine risk factors which effect severity and mortality rates in a cohort of hospitalized COVID-19 patients in KSA.Method: We reviewed medical records of hospitalized patients with confirmed COVID-19 positive results via reverse-transcriptase-polymerase-chain-reaction (RT-PCR) tests at Prince Mohammed Bin Abdulaziz Hospital, Riyadh between May and August 2020. Data were obtained for patientâs demography, body mass index (BMI), and comorbidities. Additional data on patients that required intensive care unit (ICU) admission and clinical outcomes were recorded and analyzed with Python Pandas.Results: A total of 565 COVID-19 positive patients were inducted in the study out of which, 63 (11.1%) patients died while 101 (17.9%) patients required ICU admission. Disease incidences were significantly higher in males and non-Saudi nationals. Patients with cardiovascular, respiratory, and renal diseases displayed significantly higher association with ICU admissions (p< 0.001) while mortality rates were significantly higher in COVID-19 patients with cardiovascular, respiratory, renal and neurological diseases. Univariate cox proportional hazards regression model showed that COVID-19 positive patients requiring ICU admission [Hazardâs ratio, HR=4.2 95% confidence interval, CI 2.5â 7.2); p< 0.001] with preexisting cardiovascular [HR=4.1 (CI 2.5â 6.7); p< 0.001] or respiratory [HR=4.0 (CI 2.0â 8.1); p=0.010] diseases were at significantly higher risk for mortality among the positive patients. There were no significant differences in mortality rates or ICU admissions among males and females, and across different age groups, BMIs and nationalities. Hospitalized patients with cardiovascular comorbidity had the highest risk of death (HR=2.9, CI 1.7â 5.0; p=0.020).Conclusion: Independent risk factors for critical outcomes among COVID-19 in KSA include cardiovascular, respiratory and renal comorbidities.Keywords: COVID-19, SARS-CoV-2, mortality rate, comorbidities, risk factors, KSA |
Databáze: | OpenAIRE |
Externí odkaz: |